Reddy K R, Schiff E R
Department of Internal Medicine, University of Miami School of Medicine, FL 33136, USA.
Gastroenterol Clin North Am. 1995 Dec;24(4):923-36.
Several antibiotics are known to be hepatotoxic. Apart from subtle, reversible, and often inconsequential abnormalities, cholestasis is the predominant presentation that has a protracted and disabling course. Hepatitis, like illness, is characteristic of some drugs, and chronic liver disease may evolve. It is important to recognize if a patient has an adverse reaction to a drug because continuing use of the drug in the face of hepatitis can have disastrous consequences. Chronic liver disease may ensue and progress onto cirrhosis; this has typically been seen following use of isoniazid and nitrofurantoin. Cholestatic liver disease can progress into a chronic form of a ductopenic state; this is particularly seen after antibiotic-related cholestasis.
已知有几种抗生素具有肝毒性。除了细微、可逆且通常无关紧要的异常外,胆汁淤积是主要表现,其病程迁延且使人衰弱。肝炎,如同疾病一样,是某些药物的特征,慢性肝病可能会发展。识别患者是否对药物有不良反应很重要,因为在肝炎情况下继续使用该药物可能会产生灾难性后果。慢性肝病可能会继而发展为肝硬化;这在使用异烟肼和呋喃妥因后较为常见。胆汁淤积性肝病可发展为慢性胆管开放状态;这在抗生素相关性胆汁淤积后尤为常见。